The size of the global protein assays market is estimated to grow USD 2.97 billion by 2026 from USD 1.76 billion in 2021, growing at a CAGR of 11.1% during the forecast period.
Protein assays are utilized to determine the concentration of solubilized protein. Various biochemical methods are available for the quantification, isolation, and analysis of proteins. Selection from the available protein assays is based on their chemical compatibility with the samples' buffer components to be analyzed.
The recent past has seen an increasing inclination by end-users towards the high quality and safety of drugs and their ingredients. It has led to rapid advances in molecular biology and genetic engineering, and these advancements are anticipated to drive protein analysis technology adoption during the forecast period (2020-2025). Protein assays have distinguished therapeutic applications such as protein purification, electrophoresis, cell biology, molecular biology, and various research applications.
Dynamic improvements in protein analysis and proteomics aim to elevate the call for new technologies and advanced analytical techniques to characterize therapeutic proteins, which is anticipated to boost significant growth in the protein assays market during the forecast. The protein assays market is experiencing strong growth due to substantial public-private investments in proteomics research and increased spending on pharmaceutical and biotechnology R&D for the diagnosis of diseases such as cancer and HIV. Prognostic and diagnostic tests facilitate early diagnosis and are cost-effective, reproducible, and straightforward. Therefore, assays in disease diagnosis, drug discovery, and development encourage biotechnology and bio pharmacy players to invest in research and development, driving the growth of the protein testing market.
However, stringent regulatory framework and adverse drug reactions of anticonvulsants and unapproved bipolar drugs may hamper the growth of the market. The rising application of protein content determination in various fields related to pharmacy and biotechnology has stimulated the development of the market.
Impact of COVID-19 on the global protein assay market
Since the COVID-19 virus outburst in December 2019, the virus has extended to nearly 90 countries worldwide, and the World Health Organization has declared it a public health emergency. The global impacts of the 2019 coronavirus disease (COVID-19) are already starting to be felt and will remarkably influence the protein assays market in 2020. COVID-19 can affect the global economy in three main ways: directly affecting production and demand, creating disruptions in the supply chain and need, and through its financial impact on businesses and financial markets. The COVID-19 outbreak has had effects in many ways, such as flight cancellations; travel bans and quarantines; restaurants closed; all restricted interior events; more than forty countries have declared a state of emergency; a massive downturn in the supply chain; stock market volatility; declining business confidence, growing public panic, and uncertainty about the future.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Analysed |
By Product, Type, Application, Technology, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This research report on the Global Protein Assays Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Protein Assays Market - By Product:
Protein Assays Market - By Type:
Protein Assays Market - By Technology:
Protein Assays Market - By Application:
Protein Assays Market - By End User:
Protein Assays Market - By Region:
North America is leading the market while Europe is in second place. Growth in the Pharmaceutical and biotechnological industries, a strong R & D trend in the life sciences industry, increasing private-public partnership for drug development has helped these regions dominate the market. In 2017, according to a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA), a trade group representing companies in the pharmaceutical industry in the United States, PhRMA member organizations (pharmaceutical companies) invested approximately USD 60.21. $ 1 billion in R&D, the largest biopharmaceutical R&D expenditure in the United States, in 2017. Growing demand for protein quantification in laboratories for activities ranging from protein characterization to clinical diagnostic testing and assay drugs will drive market growth in the near future.
The European protein analysis market is anticipated to experience rapid growth due to the high investments in various government and privately funded research and development programs in the region and the increased spending on the development of the pharmaceutical and biotechnology industry.
The Asia Pacific is expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques, and rising adoption of advanced Protein Assays techniques. Dye binding Protein Assays segment holds a significant share in the market based on type, due to increasing usage of dye-binding assays in disease diagnosis. Absorbance-based protein assays had a substantial share in the market based on technology due to increased sensitivity and accuracy.
Countries like China, Japan, and India in Asia-Pacific are also set to become promising markets for protein analysis shortly. Healthcare spending in Asia has increased due to the expansion of public healthcare programs and the population's growing wealth. India is anticipated to see increased spending due to a government resolution to improve health services. Besides, China and South Korea are striving to develop their biotechnology sector for diagnostic purposes. China's efforts to expand its biotech sector have yielded promising results in sectors such as vaccines and biologics, and the same can be anticipated in the protein analysis industry. However, poor performance in research and development (R & D), high cost of infrastructure, strict regulatory framework, and lack of trained resources are some of the protein analysis market limitations.
The Middle East region is anticipated to grow faster due to factors such as the extensive development of health infrastructure and the growing emphasis on research and development in the health sector.
KEY MARKET PLAYERS:
A few of the prominent companies operating in the Global Protein Assays Market profiled in this report are Abcam PLC., Bio-Rad Laboratories Inc., Biovision Inc., Cell Signaling Technology Inc., GE Healthcare, PerkinElmer Inc., Thermo Fisher Scientific, Geno Technology Inc., Lonza Group, Merck KGaA, and Novus Biologicals, LLC.
RECENT MARKET DEVELOPMENTS:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.3 Kits
5.1.4 Instruments and Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Dye-Binding Assays
5.2.3 Copper-Ion-Based Assays
5.2.4 Test Strip-Based Assays
5.2.5 Other Protein Assays
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Technology
5.3.1 Introduction
5.3.2 Absorbance-Based Protein Assays
5.3.3 Colorimetric Protein Assays
5.3.4 Fluorescence-Based Protein Assays
5.3.5 Y-o-Y Growth Analysis, By Technology
5.3.6 Market Attractiveness Analysis, By Technology
5.3.7 Market Share Analysis, By Technology
5.4 Application
5.4.1 Introduction
5.4.2 Drug Discovery & Development
5.4.3 Disease Diagnosis
5.4.4 Other Applications
5.4.5 Y-o-Y Growth Analysis, By Application
5.4.6 Market Attractiveness Analysis, By Application
5.4.7 Market Share Analysis, By Application
5.5 End User
5.5.1 Introduction
5.5.2 Academic and Research Institutes
5.5.4 Pharmaceutical & Biotechnology Companies
5.5.4 Hospitals
5.5.5 Clinical Laboratories
5.5.6 Other End Users
5.5.7 Y-o-Y Growth Analysis, By End User
5.5.8 Market Attractiveness Analysis, By End User
5.5.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Technology
6.1.3.5 By Application
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Technology
6.1.4.5 By Application
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Technology
6.1.5.5 By Application
6.1.5.6 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abcm PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories Inc
8.3 Biovision Inc
8.4 Cell Signaling Technology Inc
8.5 GE Healthcare
8.6 PerkinElmer Inc
8.7 Thermo Fisher Scientific
8.8 Geno Technology
8.9 Lonza Group
8.10 Merck KGaA
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
